By a News Reporter-Staff News Editor at Life Science Weekly — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Van Heek G Jan (Form 3) was posted on June 30, 2014.
The SIC code for this company is 2836, Biological Products, (No Diagnostic Substances).
There was one document filed with this form. The SEC file number is 0001104659-14-049453.
The contact information for this company is 245 FIRST STREET, SUITE 1800, CAMBRIDGE MA 02142, 617-444-8444.
Our editors provided additional information about Form 3: Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the ’34 Act must file with the Commission a statement of ownership regarding such security. The initial filing is on Form 3 and changes are reported on Form 4. The Annual Statement of beneficial ownership of securities is on Form 5. The forms contain information on the reporting person’s relationship to the company and on purchases and sales of such equity securities.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1021040/0001104659-14-049453-index.html.
Keywords for this news article include: SEC Filing, Van Heek G Jan, Biological Products, (No Diagnostic Substances).
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
